Field Application Scientist, NGS - NY/NJ/MidWest
Twist Bioscience- Full Time
- Junior (1 to 2 years)
Employment Type: Full-time
Location Type: Field-based (covering South Wales and the South West of England)
Illumina is expanding access to genomic technology to realize health equity for billions of people worldwide. Our work enables life-changing discoveries that transform human health through early detection and diagnosis of diseases, and new treatment options for patients. Working at Illumina means being part of something bigger than yourself, with opportunities to make a difference in every role.
The UK/IRE team is seeking a Field Application Scientist (FAS) to cover South Wales and the South West of England. This is a field-based role requiring travel across the region to support customers. The FAS partners with clinical and research customers to provide technical training, troubleshooting, and complaint resolution. This position serves as a scientific consultant during pre- and post-sales activities and collaborates with the commercial team to maximize sales growth and customer satisfaction.
Illumina is at the forefront of bringing whole genome sequencing into healthcare, driving the adoption of sequencing in the diagnosis of rare disease and emerging cancer applications. Our employees are deeply passionate about improving lives through our work. Illumina's employee benefits are industry-leading and include flexible time off, private medical insurance, compassion and care time off, leisure travel insurance, pension, employee stock purchasing program, volunteer time off, and much more.
Please refer to the original job posting for specific application instructions.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.